Logo image of ICHR

ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

USA - NASDAQ:ICHR - KYG4740B1059 - Common Stock

14.25 USD
-0.69 (-4.62%)
Last: 11/20/2025, 8:00:01 PM
14.19 USD
-0.06 (-0.42%)
After Hours: 11/20/2025, 8:00:01 PM
Fundamental Rating

3

ICHR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of ICHR have multiple concerns. ICHR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ICHR had positive earnings in the past year.
ICHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
Each year in the past 5 years ICHR had a positive operating cash flow.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

With a Return On Assets value of -4.22%, ICHR is not doing good in the industry: 65.18% of the companies in the same industry are doing better.
With a Return On Equity value of -6.03%, ICHR is not doing good in the industry: 63.39% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROIC N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

ICHR has a Gross Margin of 9.80%. This is amonst the worse of the industry: ICHR underperforms 88.39% of its industry peers.
ICHR's Gross Margin has declined in the last couple of years.
ICHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

3

2. Health

2.1 Basic Checks

ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ICHR has more shares outstanding than it did 1 year ago.
ICHR has more shares outstanding than it did 5 years ago.
ICHR has a better debt/assets ratio than last year.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICHR has an Altman-Z score of 2.53. This is not the best score and indicates that ICHR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ICHR (2.53) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.17 indicates that ICHR is not too dependend on debt financing.
ICHR has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: ICHR outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 2.53
ROIC/WACCN/A
WACC10.52%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.08 indicates that ICHR has no problem at all paying its short term obligations.
ICHR has a Current ratio (3.08) which is in line with its industry peers.
ICHR has a Quick Ratio of 1.33. This is a normal value and indicates that ICHR is financially healthy and should not expect problems in meeting its short term obligations.
ICHR has a Quick ratio of 1.33. This is in the lower half of the industry: ICHR underperforms 79.46% of its industry peers.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 1.33
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

ICHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1400.00%, which is quite impressive.
ICHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.82% yearly.
The Revenue has grown by 16.86% in the past year. This is quite good.
The Revenue has been growing slightly by 6.46% on average over the past years.
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%

3.2 Future

The Earnings Per Share is expected to grow by 73.13% on average over the next years. This is a very strong growth
Based on estimates for the next years, ICHR will show a quite strong growth in Revenue. The Revenue will grow by 8.59% on average per year.
EPS Next Y157.12%
EPS Next 2Y162.91%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 47.50 indicates a quite expensive valuation of ICHR.
ICHR's Price/Earnings is on the same level as the industry average.
ICHR is valuated expensively when we compare the Price/Earnings ratio to 25.07, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.88, which indicates a correct valuation of ICHR.
Based on the Price/Forward Earnings ratio, ICHR is valued cheaply inside the industry as 91.07% of the companies are valued more expensively.
ICHR is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 47.5
Fwd PE 12.88
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICHR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 114.54
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ICHR's earnings are expected to grow with 106.44% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y162.91%
EPS Next 3Y106.44%

0

5. Dividend

5.1 Amount

No dividends for ICHR!.
Industry RankSector Rank
Dividend Yield N/A

ICHOR HOLDINGS LTD

NASDAQ:ICHR (11/20/2025, 8:00:01 PM)

After market: 14.19 -0.06 (-0.42%)

14.25

-0.69 (-4.62%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners98.94%
Inst Owner Change-5.57%
Ins Owners2.1%
Ins Owner Change6.83%
Market Cap489.20M
Revenue(TTM)957.34M
Net Income(TTM)-40.76M
Analysts78.46
Price Target25.33 (77.75%)
Short Float %7.98%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.69%
Min EPS beat(2)-79.27%
Max EPS beat(2)-42.12%
EPS beat(4)0
Avg EPS beat(4)-46.48%
Min EPS beat(4)-79.27%
Max EPS beat(4)-9.51%
EPS beat(8)2
Avg EPS beat(8)-601.07%
EPS beat(12)4
Avg EPS beat(12)-374.76%
EPS beat(16)6
Avg EPS beat(16)-280.24%
Revenue beat(2)1
Avg Revenue beat(2)0.11%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)0.45%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)0.45%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)6
Avg Revenue beat(12)-0.3%
Revenue beat(16)8
Avg Revenue beat(16)-0.27%
PT rev (1m)2.76%
PT rev (3m)-3.87%
EPS NQ rev (1m)-76.85%
EPS NQ rev (3m)-82.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-47.36%
Revenue NQ rev (1m)-5.02%
Revenue NQ rev (3m)-5.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE 47.5
Fwd PE 12.88
P/S 0.51
P/FCF N/A
P/OCF 26.84
P/B 0.72
P/tB 1.64
EV/EBITDA 114.54
EPS(TTM)0.3
EY2.11%
EPS(NY)1.11
Fwd EY7.76%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.53
OCFY3.73%
SpS27.89
BVpS19.7
TBVpS8.69
PEG (NY)0.3
PEG (5Y)N/A
Graham Number11.53
Profitability
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.8%
FCFM N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 24.68
Cap/Depr 118.71%
Cap/Sales 3.9%
Interest Coverage N/A
Cash Conversion 383.91%
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 1.33
Altman-Z 2.53
F-Score4
WACC10.52%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
EPS Next Y157.12%
EPS Next 2Y162.91%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%
EBIT growth 1Y-86.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year222.78%
EBIT Next 3Y56.45%
EBIT Next 5Y48.64%
FCF growth 1Y-149.43%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-69.02%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%

ICHOR HOLDINGS LTD / ICHR FAQ

What is the ChartMill fundamental rating of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICHR.


What is the valuation status of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a valuation rating of 4 / 10 to ICHOR HOLDINGS LTD (ICHR). This can be considered as Fairly Valued.


How profitable is ICHOR HOLDINGS LTD (ICHR) stock?

ICHOR HOLDINGS LTD (ICHR) has a profitability rating of 2 / 10.


What is the valuation of ICHOR HOLDINGS LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ICHOR HOLDINGS LTD (ICHR) is 47.5 and the Price/Book (PB) ratio is 0.72.


Can you provide the expected EPS growth for ICHR stock?

The Earnings per Share (EPS) of ICHOR HOLDINGS LTD (ICHR) is expected to grow by 157.12% in the next year.